295
Views
11
CrossRef citations to date
0
Altmetric
Research Article

PET imaging of liposomes labeled with an [18F]-fluorocholesteryl ether probe prepared by automated radiosynthesis

, , , &
Pages 295-305 | Received 01 Feb 2012, Accepted 21 May 2012, Published online: 18 Jul 2012

References

  • Alavi, A., Basu, S. (2008). Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time? Eur J Nucl Med Mol Imaging 35:1554–1559.
  • Allen, T. M., Hansen, C., Martin, F., Redemann, C., Yauyoung, A. (1991). Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066:29–36.
  • Bangham, A. D., Horne, R. W. (1964). Negative staining of phospholipids and their structural modification by surface-active agents as observed in electron microscope. J Mol Biol 8:660–668.
  • Bao, A., Goins, B., Klipper, R., Negrete, G., Mahindaratne, M., Phillips, W. T. (2003a). A novel liposome radiolabeling method using 99mTc-”SNS/S” complexes: in vitro and in vivo evaluation. J Pharm Sci 92:1893–1904.
  • Bao, A., Goins, B., Klipper, R., Negrete, G., Phillips, W. T. (2003b). Re-186-liposome labeling using Re-186-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats. J Nucl Med 44:1992–1999.
  • Bao, A., Goins, B., Klipper, R., Negrete, G., Phillips, W. T. (2004). Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies. J Pharmacol Exp Ther 308:419–425.
  • Bateman, T. M. (2012). Advantages and disadvantages of PET and SPECT in a busy clinical practice. J Nucl Cardiol 19:3–8.
  • Chang, Y. J., Chang, C. H., Yu, C. Y., Chang, T. J., Chen, L. C., Chen, M. H., et al. (2010). Therapeutic efficacy and microSPECT/CT imaging of Re-188-DXR-liposome in a C26 murine colon carcinoma solid tumor model. Nucl Med Biol 37:95–104.
  • Corvo, M. L., Boerman, O. C., Oyen, W. J. G., Van Bloois, L., Cruz, M. E. M., Crommelin, D. J. A., et al. (1999). Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. Biochim Biophys Acta 1419:325–334.
  • Gabizon, A., Goren, D., Horowitz, A. T., Tzemach, D., Lossos, A., Siegal, T. (1997). Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. Adv Drug Del Rev 24:337–344.
  • Gabizon, A., Huberty, J., Starubinger, M., Price, D. C., Papahadjopoulos, D. (1988). An improved method for in vivo tracing and imaging of liposomes using a gallium 67-deferoxamine complex. J Liposome Res 1:123–135.
  • Gabizon, A., Shmeeda, H., Barenholz, Y. (2003). Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet 42:419–436.
  • Gambhir, S. S. (2002). Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2:683–693.
  • Goins, B. (2008). Radiolabeled lipid nanoparticles for diagnostic imaging. Expert Opin Med Diagn 2:853–873.
  • Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D., Peters, A. M., Vile, R. G., et al. (2001). Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 7:243–254.
  • Kamps, J. A., Koning, G. A., Velinova, M. J., Morselt, H. W., Wilkens, M., Gorter, A., et al. (2000). Uptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer. J Drug Target 8:235–245.
  • Kaasgaard, T., Andresen, T. L. (2010). Liposomal cancer therapy: exploiting tumor characteristics. Expert Opin Drug Deliv 7:225–243.
  • Kizelsztein, P., Ovadia, H., Garbuzenko, O., Sigal, A., Barenholz, Y. (2009). Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis. J Neuroimmunol 213:20–25.
  • Klibanov, A. L., Maruyama, K., Torchilin, V. P., Huang, L. (1990). Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235–237.
  • Laverman, P., Dams, E. T. M., Oyen, W. J. G., Storm, G., Koenders, E. B., Prevost, R., et al. (1999). A novel method to label liposomes with Tc-99m by the hydrazino nicotinyl derivative. J Nucl Med 40:192–197.
  • Li, S., Goins, B., Phillips, W. T., Bao, A. (2011). Remote-loading labeling of liposomes with (99m)Tc-BMEDA and its stability evaluation: effects of lipid formulation and pH/chemical gradient. J Liposome Res 21:17–27.
  • Maeda, H. (2001). The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–207.
  • Marik, J., Tartis, M. S., Zhang, H., Fung, J. Y., Kheirolomoom, A., Sutcliffe, J. L., et al. (2007). Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP). Nucl Med Biol 34:165–171.
  • Matsumura, Y., Maeda, H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–6392.
  • Mishra, B., Patel, B. B., Tiwari, S. (2010). Colloidal nanocarriers: a review on formulation technology, types, and applications toward targeted drug delivery. Nanomedicine 6:9–24.
  • Moghimi, S. M., Hamad, I., Andresen, T. L., Jorgensen, K., Szebeni, J. (2006). Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production. FASEB J 20:2591–2593.
  • Moghimi, S. M., Hunter, A. C., Murray, J. C. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318.
  • Oku, N. (1999). Delivery of contrast agents for positron emission tomography imaging by liposomes. Adv Drug Deliv Rev 37:53–61.
  • Oku, N., Tokudome, Y., Tsukada, H., Kosugi, T., Namba, Y., Okada, S. (1996). In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography. Biopharm Drug Dispos 17:435–441.
  • Oku, N., Tokudome, Y., Tsukada, H., Okada, S. (1995). Real-time analysis of liposomal trafficking in tumor-bearing mice by use of positron emission tomography. Biochim Biophys Acta 1238:86–90.
  • Paudyal, B., Paudyal, P., Oriuchi, N., Hanaoka, H., Tominaga, H., Endo, K. (2011). Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts. Cancer Sci 102:117–121.
  • Paudyal, P., Paudyal, B., Hanaoka, H., Oriuchi, N., Iida, Y., Yoshioka, H., et al. (2010). Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with Cu-labeled trastuzumab PET. Cancer Sci, 101:1045–1050.
  • Petersen, A. L., Binderup, T., Jølck, R. I., Rasmussen, P., Henriksen, J. R., Pfeifer, A. K., et al. (2012). Positron emission tomography evaluation of somatostatin receptor targeted (64)Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model. J Control Release 160:254–263.
  • Petersen, A. L., Binderup, T., Rasmussen, P., Henriksen, J. R., Elema, D. R., Kjaer, A., et al. (2011). 64Cu loaded liposomes as positron emission tomography imaging agents. Biomaterials 32:2334–2341.
  • Phillips, W. T., Goins, B. A., Bao, A. (2009). Radioactive liposomes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:69–83.
  • Phillips, W. T., Rudolph, A. S., Goins, B., Timmons, J. H., Klipper, R., Blumhardt, R. (1992). A simple method for producing a Tc-99m-labeled liposome which is stable in vivo. Nucl Med Biol 19:539–543, 545–547.
  • Poelstra, K. P., Prakash, J., Beljaars, L. (2012). Drug targeting to the diseased liver. J Control Release 2012 Feb 17. [Epub ahead of print].
  • Pool, G. L., French, M. E., Edwards, R. A., Huang, L., Lumb, R. H. (1982). Use of radiolabeled hexadecyl cholesteryl ether as a liposome marker. Lipids 17:448–452.
  • Poste, G., Bucana, C., Raz, A., Bugelski, P., Kirsh, R., Fidler, I. J. (1982). Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res 42:1412–1422.
  • Rahmim, A., Zaidi, H. (2008). PET versus SPECT: strengths, limitations, and challenges. Nucl Med Commun 29:193–207.
  • Scherphof, G. L., Dijkstra, J., Spanjer, H. H., Derksen, J. T. P., Roerdink, F. H. (1985). Uptake and intracellular processing of targeted and nontargeted liposomes by rat Kupffer cells in vivo and in vitro. Ann NY Acad Sci 446:368–384.
  • Seo, J. W., Mahakian, L. M., Kheirolomoom, A., Zhang, H., Meares, C. F., Ferdani, R., et al. (2010). Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects. Bioconj Chem 21:1206–1215.
  • Seo, J. W., Qin, S., Mahakian, L. M., Watson, K. D., Kheirolomoom, A., Ferrara, K. W. (2011). Positron emission tomography imaging of the stability of Cu-64 labeled dipalmitoyl and distearoyl lipids in liposomes. J Control Release 151:28–34.
  • Seo, J. W., Zhang, H., Kukis, D. L., Meares, C. F., Ferrara, K. W. (2008). A novel method to label preformed liposomes with (CU)-C-64 for positron emission tomography (PET) imaging. Bioconj Chem 19:2577–2584.
  • Sripada, P. K. (1986). A simple method for the synthesis of cholesteryl ethers. J Lipid Res 27:352–353.
  • Stein, Y., Halperin, G., Stein, O. (1980). Biological stability of [3H]cholesteryl oleoyl ether in cultured fibroblasts and intact rat. FEBS Lett 111:104–106.
  • Suehiro, M., Burgman, P., Carlin, S., Burke, S., Yang, G. B., Ouerfelli, O., et al. (2009). Radiosynthesis of [I-131]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker—is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker? Nucl Med Biol 36:477–487.
  • Suehiro, M., Vallabhajosula, S., Goldsmith, S. J., Ballon, D. J. (2007). Investigation of the role of the base in the synthesis of [F-18]FLT. Appl Radiat Isot 65:1350–1358.
  • Tilcock, C., Ahkong, Q. F., Fisher, D. (1994). Tc-99m-labeling of lipid vesicles containing the lipophilic chelator PE-DTTA: effect of tin-to-chelate ratio, chelate content, and surface polymer on labeling efficiency and biodistribution behavior. Nucl Med Biol 21:89–96.
  • Urakami, T., Akai, S., Katayama, Y., Harada, N., Tsukada, H., Oku, N. (2007). Novel amphiphilic probes for [F-18]-radiolabeling preformed liposomes and determination of liposomal trafficking by positron emission tomography. J Med Chem 50:6454–6457.
  • Urakami, T., Kawaguchi, A. T., Akai, S., Hatanaka, K., Koide, H., Shimizu, K., et al. (2009). In vivo distribution of liposome-encapsulated hemoglobin determined by positron emission tomography. Artif Organs 33:164–168.
  • van Nostrum, C. F. (2011). Covalently cross-linked amphiphilic block copolymer micelles. Soft Matter 7:3246–3259.
  • Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., Gambhir, S. S. (2008). Molecular imaging in drug development. Nat Rev Drug Discov 7:591–607.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.